Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effect
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
URI: http://hdl.handle.net/20.500.11940/1039
PMID: 24976690
DOI: 10.1155/2014/798060
ISSN: 0962-9351
Fecha de publicación
2014Título de revista
MEDIATORS OF INFLAMMATION
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)